(Q26825269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

systematic review

1 reference

PubMed publication ID

1 reference

13 August 2023

The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

13 November 2019

1 reference

13 November 2019

cholagogues and choleretics

1 reference

PubMed publication ID

24053454

non-alcoholic steatohepatitis

1 reference

inferred from abstract

author

Han Ma

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

Yi-peng Chen

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

Zun Xiang

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

7

You-ming Li

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

4

Yue-fang Ye

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

5

Lin Zheng

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Yi-da Yang

series ordinal

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Xi Jin

series ordinal

8

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

1 reference

23 September 2013

5 references

21 March 2019

13 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

13 August 2023

5 references

21 March 2019

13 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

13 August 2023

13

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

140

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

22 February 2020

copyright license

3 references

21 March 2019

13 November 2019

on focus list of Wikimedia project

13 August 2023

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Steatohepatitis: a tale of two "hits"?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Long-term follow-up of patients with NAFLD and elevated liver enzymes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Lifestyle modification as the primary treatment of NASH.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Epidemiology and natural history of NAFLD and NASH.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-140

Hepatoprotective bile acid 'ursodeoxycholic acid (UDCA)' Property and difference as bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-140

Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-140

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-140

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-140

Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848865

NASH and thiazolidinediones: not to be taken lightly

28 November 2018

1 reference

12 December 2020

Ursodeoxycholic acid dose-dependently improves liver injury in rats fed a methionine- and choline-deficient diet

1 reference

12 December 2020

A position statement on NAFLD/NASH based on the EASL 2009 special conference

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation

1 reference

12 December 2020

miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease

1 reference

12 December 2020

Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease

1 reference

12 December 2020

Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results

1 reference

12 December 2020

UDCA for NASH: end of the story?

1 reference

12 December 2020

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

1 reference

12 December 2020

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis

1 reference

12 December 2020

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-140

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/1471-230X-13-140

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 February 2020

1033586511

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24053454%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

24053454

2 references